Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company SAB Biotherapeutics Inc.
DescriptionHuman polyclonal Ig produced from transchromosomic cattle that targets Middle East respiratory syndrome (MERS) coronavirus spike (S) protein
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard IndicationViral respiratory infection
Indication DetailsTreat Middle East respiratory syndrome (MERS) coronavirus infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today